Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
First Edition BOGP (0)
United States (2)
Access
Musculoskeletal/Multiple Sclerosis (MS) (1)
Private Public Partnership (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase I